BioXcel Therapeutics, Inc.

Track this case

Case Number:

1:26-bk-11360

Court:

Delaware

Nature of Suit:

Firms

Companies

Sectors & Industries:

  1. September 08, 2026

    Meet The Attorneys Guiding BioXcel Therapeutics' Ch. 11

    A group of attorneys from Young Conaway Stargatt & Taylor LLP and Cooley LLP is representing artificial intelligence-powered drug company BioXcel Therapeutics Inc. in its Chapter 11 case.

  2. September 01, 2026

    Catching Up With New Bankruptcy Case Action

    A winery in California's Napa Valley struggling to recover from wildfires hit Chapter 11. A vertical farming startup whose products were distributed by a dozen supermarket chains was forced to liquidate. And a military contractor foundered after losing a crucial government agency as a client.

  3. August 28, 2026

    AI-Bolstered Drug Co. Hits Ch. 11 With $105M Debt

    A company that uses artificial intelligence to explore new uses for existing drugs entered bankruptcy in Delaware with over $104 million in debt and a stalking horse bidder.